Patrons and trustees
Baroness Morgan of Drefelin:
Breast Cancer Now Chief Executive since April 2015, Delyth Morgan previously enjoyed a varied voluntary sector career, which included ten years as Breakthrough Breast Cancer Chief Executive and Chief Executive of Breast Cancer Campaign in 2011. In 2014, Delyth played a pivotal role in the merger of Breast Cancer Campaign and Breakthrough Breast Cancer. Occupying a number of Government ministerial posts from 2007, she now sits as an independent peer in the House of Lords.
Delyth says, "I have seen first hand how devastating a diagnosis can be and I am convinced there must be more that can be done to improve survival and quality of life for people with pancreatic cancer."
Lynne Walker (Chair)
"I recently celebrated my five-year pancreatic cancer survival anniversary and was delighted to accept the invitation to join the Board of Trustees.
"I want to use my personal experience and professional expertise to further the work of improving the patient experience, to increase early diagnosis and improve the appalling survival rates for pancreatic cancer.
"This is a very exciting time to contribute to the work of Pancreatic Cancer UK as it raises the profile of this terrible disease and funds great research utilising money raised by so many fantastic supporters. I was honoured to give evidence to the All-Party Parliamentary Group on pancreatic cancer.
"I initially trained as a teacher before serving as a school inspector and as a senior manager in a university. Until I retired last year I ran my own consultancy company specialising in change management, strategic development planning and team development programmes both in the UK and overseas."
Daniel Benjamin (Treasurer)
Daniel is an experienced executive and non-executive with a track record in the public, private and voluntary sectors. He has had responsibility for Finance, Human Resources, Corporate and Information Governance, Risk Management, Information Technology and Programme Management.
Daniel serves as Treasurer of Pancreatic Cancer UK, Friends of the Lake District and the Wilmslow Guild.
Daniel’s personal interests include art, heritage, history, football, travelling and walking.
Tim is a solicitor and a partner of Mills & Reeve, one of the UK’s leading law firms, with some 22 years of professional and practice management experience.
“I lost my father to pancreatic cancer when he was only 56 and ever since I have been looking for a way to fight the fight he never could and to permanently change things for the better. It means a great deal to me to be a trustee of such an innovative and effective charity and I want to use my professional skills, my enthusiasm and my commitment to make a material difference and to help make possible the early detection and defeat of such a dreadful disease.”
"I am privileged to be a survivor of pancreatic cancer and honoured to now be a Trustee as well.
"I have been involved with Pancreatic Cancer UK for a number of years and hope sharing the experience of living with and beyond cancer as well as my professional knowledge and experience of the NHS will contribute to the team effort of improving diagnosis and survival.
"I believe that by raising the profile of pancreatic cancer, campaigning for improvements in treatment and investment in research we will bring about hope for the future.
"I originally trained as a nurse at St Thomas’ Hospital in London, and specialised in oncology and palliative care some twenty years ago. Since then, I have worked in a wide variety of settings and held a number of senior management roles, both in the NHS and the voluntary sector. I am currently the Chief Executive of a hospice charity in Kent. Throughout my career, I have always been strongly motivated to ensure that the best interests of patients and families can be achieved, and to lead a drive towards equity and excellence in care. I have a good understanding of charity management and governance, having studied this at post-graduate level.
"I have a commitment and passion for supporting Pancreatic Cancer UK, due to my personal and professional experience of this disease, and the distress it can cause, particularly as it can often be so difficult to achieve last wishes due to the short prognosis from diagnosis to death. Both my father-in-law and aunt died from pancreatic cancer, at young ages. I am encouraged by the great strides in research leading to improved outcomes, and feel motivated to be part of delivering the charity’s vision that everyone with pancreatic cancer survives to live long and well."
Stuart is a Chartered Certified Accountant and was, until April 2016, CEO of Bupa and prior to that spent 26 years with Diageo Plc in finance and general management roles, concluding as President, Diageo International from 2004-2011.
"My father died of pancreatic cancer in 1987, at the age of 60. It was during my time at Bupa that I discovered that pancreatic cancer is incredibly tough to diagnose, research, treat and survive; one of the toughest amongst all forms of cancer. It is also the most poorly funded area of cancer research and support.
"I believe my commercial and leadership skills, combined with my partnering and health sector experience, equip me to make a very real contribution to tackling this situation together and bring about substantive improvements for all affected by this dreadful disease.”
Professor Stephen K. Smith (Co-opted Trustee and Chair of Scientific Advisory Board)
Stephen has established an International Academic and Health Consultancy since returning from Melbourne at the end of 2015 where he held the position of Dean of the Faculty of Medicine Dentistry and Health Sciences at the University of Melbourne and Chair Melbourne Health Academic Centre.
“My mother died of pancreatic cancer and it was devastatingly quick from the point of diagnosis. Even though my work enables me to have every opportunity to “know” the system, I feel strongly there is so much more that could be done to improve patient management from the GP, to nurse, to consultant and finally the cancer specialist centre. As a trustee of Pancreatic Cancer UK I will do everything in my power to make this happen.”
Naureen is a Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of gastrointestinal cancers and an Honorary Clinical Senior Lecturer within the Division of Clinical Studies at the Institute of Cancer Research.
Her research interests in gastrointestinal cancers (oesophageal, gastric, pancreatic, neuroendocrine and colorectal) are focussed on earlier phase clinical trials, novel therapeutics and the delivery of individualised medicine to patients with gastrointestinal cancers.
Naureen says: “As someone who is involved in managing and caring for people with pancreatic cancer, I see first-hand the impact this devastating disease has on patients and their carers. I am therefore delighted to support and share my professional expertise with this amazing charity, as it aims to transform awareness, outcomes and patient experience in pancreatic cancer.”